P2672A role for glucose metabolism in adaptive immunity dysregulation in patients with acute coronary syndromes
Davide Flego(Università Cattolica del Sacro Cuore), Giovanna Liuzzo(Agostino Gemelli University Polyclinic), Giulio Russo(Università Cattolica del Sacro Cuore), Filippo Crea(Università Cattolica del Sacro Cuore), Anna Severino(Università Cattolica del Sacro Cuore), Francesco Canonico(University of Milano-Bicocca), Claudia Lucci(Università Cattolica del Sacro Cuore), Aureliano Ruggio(Università Cattolica del Sacro Cuore), Daniela Pedicino(Agostino Gemelli University Polyclinic), Giulia Angelini(Università Cattolica del Sacro Cuore), Ramona Vinci(Unknown), Eugenia Pisano(Agostino Gemelli University Polyclinic)
Cited by 0
Related Papers
Ischemia and No Obstructive Coronary Artery Disease (INOCA)
|Circulation|2017|745
Bariatric–metabolic surgery versus lifestyle intervention plus best medical care in non-alcoholic steatohepatitis (BRAVES): a multicentre, open-label, randomised trial
|The Lancet|2023|338
Comparative effects of guided vs. potent P2Y12 inhibitor therapy in acute coronary syndrome: a network meta-analysis of 61 898 patients from 15 randomized trials
|European Heart Journal|2021|150
Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction
|Frontiers in Physiology|2019|130